Julia M L Brotherton1, Bette Liu2, Basil Donovan3, John M Kaldor4, Marion Saville5. 1. National HPV Vaccination Program Register, VCS Inc., PO Box 310, East Melbourne 8002, Victoria, Australia; Discipline of Paediatrics and Child Health, University of Sydney, Locked Bag 4001, Westmead 2145, New South Wales, Australia; Melbourne School of Population and Global Health, 207 Bouverie Street, The University of Melbourne, Parkville, Victoria 2010, Australia. Electronic address: jbrother@vcs.org.au. 2. The Kirby Institute, University of New South Wales, Sydney 2052, New South Wales, Australia. Electronic address: bette.liu@unsw.edu.au. 3. The Kirby Institute, University of New South Wales, Sydney 2052, New South Wales, Australia; Sydney Sexual Health Centre, Sydney Hospital, PO Box 1614, Sydney 2001, New South Wales, Australia. Electronic address: bdonovan@kirby.unsw.edu.au. 4. The Kirby Institute, University of New South Wales, Sydney 2052, New South Wales, Australia. Electronic address: jkaldor@kirby.unsw.edu.au. 5. National HPV Vaccination Program Register, VCS Inc., PO Box 310, East Melbourne 8002, Victoria, Australia. Electronic address: msaville@vcs.org.au.
Abstract
BACKGROUND: Accurate estimates of coverage are essential for estimating the population effectiveness of human papillomavirus (HPV) vaccination. Australia has a purpose built National HPV Vaccination Program Register for monitoring coverage, however notification of doses administered to young women in the community during the national catch-up program (2007-2009) was not compulsory. In 2011, we undertook a population-based mobile phone survey of young women to independently estimate HPV vaccination coverage. METHODS: Randomly generated mobile phone numbers were dialed to recruit women aged 22-30 (age eligible for HPV vaccination) to complete a computer assisted telephone interview. Consent was sought to validate self reported HPV vaccination status against the national register. Coverage rates were calculated based on self report and weighted to the age and state of residence structure of the Australian female population. These were compared with coverage estimates from the register using Australian Bureau of Statistics estimated resident populations as the denominator. RESULTS: Among the 1379 participants, the national estimate for self reported HPV vaccination coverage for doses 1/2/3, respectively, weighted for age and state of residence, was 64/59/53%. This compares with coverage of 55/45/32% and 49/40/28% based on register records, using 2007 and 2011 population data as the denominators respectively. Some significant differences in coverage between the states were identified. 20% (223) of women returned a consent form allowing validation of doses against the register and provider records: among these women 85.6% (538) of self reported doses were confirmed. CONCLUSIONS: We confirmed that coverage rates for young women vaccinated in the community (at age 18-26 years) are underestimated by the national register and that under-notification is greater for second and third doses. Using 2011 population estimates, rather than estimates contemporaneous with the program rollout, reduces register-based coverage estimates further because of large population increases due to immigration since the program.
BACKGROUND: Accurate estimates of coverage are essential for estimating the population effectiveness of human papillomavirus (HPV) vaccination. Australia has a purpose built National HPV Vaccination Program Register for monitoring coverage, however notification of doses administered to young women in the community during the national catch-up program (2007-2009) was not compulsory. In 2011, we undertook a population-based mobile phone survey of young women to independently estimate HPV vaccination coverage. METHODS: Randomly generated mobile phone numbers were dialed to recruit women aged 22-30 (age eligible for HPV vaccination) to complete a computer assisted telephone interview. Consent was sought to validate self reported HPV vaccination status against the national register. Coverage rates were calculated based on self report and weighted to the age and state of residence structure of the Australian female population. These were compared with coverage estimates from the register using Australian Bureau of Statistics estimated resident populations as the denominator. RESULTS: Among the 1379 participants, the national estimate for self reported HPV vaccination coverage for doses 1/2/3, respectively, weighted for age and state of residence, was 64/59/53%. This compares with coverage of 55/45/32% and 49/40/28% based on register records, using 2007 and 2011 population data as the denominators respectively. Some significant differences in coverage between the states were identified. 20% (223) of women returned a consent form allowing validation of doses against the register and provider records: among these women 85.6% (538) of self reported doses were confirmed. CONCLUSIONS: We confirmed that coverage rates for young women vaccinated in the community (at age 18-26 years) are underestimated by the national register and that under-notification is greater for second and third doses. Using 2011 population estimates, rather than estimates contemporaneous with the program rollout, reduces register-based coverage estimates further because of large population increases due to immigration since the program.
Authors: Electra D Paskett; Jessica L Krok-Schoen; Michael L Pennell; Cathy M Tatum; Paul L Reiter; Juan Peng; Brittany M Bernardo; Rory C Weier; Morgan S Richardson; Mira L Katz Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-04 Impact factor: 4.254
Authors: Kate T Simms; Michaela Hall; Megan A Smith; Jie-Bin Lew; Suzanne Hughes; Susan Yuill; Ian Hammond; Marion Saville; Karen Canfell Journal: PLoS One Date: 2017-01-17 Impact factor: 3.240
Authors: Michaela T Hall; Kate T Simms; Jie-Bin Lew; Megan A Smith; Marion Saville; Karen Canfell Journal: PLoS One Date: 2018-02-14 Impact factor: 3.240
Authors: Megan A Smith; Dorota Gertig; Michaela Hall; Kate Simms; Jie-Bin Lew; Michael Malloy; Marion Saville; Karen Canfell Journal: BMC Health Serv Res Date: 2016-04-26 Impact factor: 2.655
Authors: Karen Canfell; Marion Saville; Michael Caruana; Val Gebski; Jessica Darlington-Brown; Julia Brotherton; Stella Heley; Philip E Castle Journal: BMJ Open Date: 2018-01-26 Impact factor: 2.692